Sanofi said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice ...

Investing.com -- Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier&Rice to sell a controlling stake in its consumer healthcare unit ...

Reports that an Opella sale was close triggered criticism from government opponents in recent weeks over the potential loss of a strategic asset, prompting workers to strike and rival bidder PAI ...

The sale to CD&R sparked concerns over potential shortages in future of brands such as Doliprane, because in France the government rationed paracetamol during the Covid-19 pandemic. Worries also ...

The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton ...

CDs in better condition fetch higher prices, and don't forget that external parts matter too. Check marketplaces for prices to set a realistic and attractive sale price. If you look for listings ...

The proposed transaction would see the French pharmaceutical company sell a controlling 50% stake in Opella--home to brands such as Allegra, Dulcolax and IcyHot--to CD&R, French state-owned ...